1. Home
  2. PCSC vs COYA Comparison

PCSC vs COYA Comparison

Compare PCSC & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCSC
  • COYA
  • Stock Information
  • Founded
  • PCSC 2024
  • COYA 2020
  • Country
  • PCSC United States
  • COYA United States
  • Employees
  • PCSC N/A
  • COYA N/A
  • Industry
  • PCSC
  • COYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCSC
  • COYA Health Care
  • Exchange
  • PCSC NYSE
  • COYA Nasdaq
  • Market Cap
  • PCSC 114.2M
  • COYA 99.8M
  • IPO Year
  • PCSC 2024
  • COYA 2022
  • Fundamental
  • Price
  • PCSC $10.55
  • COYA $6.23
  • Analyst Decision
  • PCSC
  • COYA Strong Buy
  • Analyst Count
  • PCSC 0
  • COYA 3
  • Target Price
  • PCSC N/A
  • COYA $16.67
  • AVG Volume (30 Days)
  • PCSC 6.9K
  • COYA 60.2K
  • Earning Date
  • PCSC 01-01-0001
  • COYA 08-11-2025
  • Dividend Yield
  • PCSC N/A
  • COYA N/A
  • EPS Growth
  • PCSC N/A
  • COYA N/A
  • EPS
  • PCSC N/A
  • COYA N/A
  • Revenue
  • PCSC N/A
  • COYA $3,685,107.00
  • Revenue This Year
  • PCSC N/A
  • COYA $106.97
  • Revenue Next Year
  • PCSC N/A
  • COYA N/A
  • P/E Ratio
  • PCSC $45.84
  • COYA N/A
  • Revenue Growth
  • PCSC N/A
  • COYA N/A
  • 52 Week Low
  • PCSC $10.02
  • COYA $4.65
  • 52 Week High
  • PCSC $10.74
  • COYA $10.24
  • Technical
  • Relative Strength Index (RSI)
  • PCSC N/A
  • COYA 62.20
  • Support Level
  • PCSC N/A
  • COYA $5.57
  • Resistance Level
  • PCSC N/A
  • COYA $6.14
  • Average True Range (ATR)
  • PCSC 0.00
  • COYA 0.36
  • MACD
  • PCSC 0.00
  • COYA 0.05
  • Stochastic Oscillator
  • PCSC 0.00
  • COYA 87.25

About PCSC PERCEPTIVE CAP SOLUTIONS CORP

Perceptive Capital Solutions Corp is a blank check company.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Share on Social Networks: